BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3333220)

  • 1. [Acquired and congenital antithrombin III deficiency. Discussion of a clinical case].
    De Blasio F; De Filippis R; Bucci N; Formato A; Pezza A
    Arch Monaldi Mal Torace; 1987; 42(2):205-13. PubMed ID: 3333220
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of thromboembolism during pregnancy in 3 sisters with congenital antithrombin III deficiency and decreased inducible fibrinolysis].
    Schoch U; Zanetti E; von Felten A
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1807-10. PubMed ID: 2962279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial antithrombin III deficiency.
    Winter JH; Fenech A; Ridley W; Bennett B; Cumming AM; Mackie M; Douglas AS
    Q J Med; 1982; 51(204):373-95. PubMed ID: 7156320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antithrombin III deficiency and pregnancy. Apropos of a case].
    Tissot H; Vergnes MC; Serville F; Dallay D; Gonnet JM; Dubecq JP
    Rev Fr Gynecol Obstet; 1990; 85(7-9):473-7. PubMed ID: 2237157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prophylaxis of thrombosis in a pregnant woman with congenital antithrombin III deficiency: changes in hemostatic molecular markers before the onset of thrombosis].
    Inomoto T; Takamoto M; Horiuchi N; Sato K; Fujino O; Oka K; Tomonari A; Uno Y; Sigekiyo T
    Rinsho Ketsueki; 1992 Sep; 33(9):1166-71. PubMed ID: 1433937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary antithrombin III deficiency and pregnancy: report of two cases and review of the literature.
    Nelson DM; Stempel LE; Brandt JT
    Obstet Gynecol; 1985 Jun; 65(6):848-53. PubMed ID: 4039808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of pregnancy in women with antithrombin III congenital defect: report of four cases.
    De Stefano V; Leone G; De Carolis S; Ferrelli R; Di Donfrancesco A; Moneta E; Bizzi B
    Thromb Haemost; 1988 Apr; 59(2):193-6. PubMed ID: 3164529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin therapy for congenital antithrombin III deficiency in pregnancy.
    Neerhof MG; Krewson DP; Haut M; Librizzi RJ
    Am J Perinatol; 1993 Jul; 10(4):311-2. PubMed ID: 8397570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Congenital deficiency of antithrombin III].
    Finazzi G; Barbui T
    Haematologica; 1990; 75 Suppl 2():6-13. PubMed ID: 2201606
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombin III concentrate. Thromboprophylaxis during pregnancy in a patient with congenital antithrombin III deficiency.
    Tengborn L; Bengtsson T
    Acta Obstet Gynecol Scand; 1986; 65(4):375-6. PubMed ID: 3739652
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombin III concentrates--are they clinically useful?
    Lechner K; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):340-8. PubMed ID: 7667814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin.
    Hellgren M; Tengborn L; Abildgaard U
    Gynecol Obstet Invest; 1982; 14(2):127-41. PubMed ID: 7117919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited antithrombin deficiency: a review.
    Patnaik MM; Moll S
    Haemophilia; 2008 Nov; 14(6):1229-39. PubMed ID: 19141163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial and venous thrombosis and prothrombotic fibrin clot phenotype in a Polish family with type 1 antithrombin deficiency (antithrombin Krakow).
    Celinska-Lowenhoff M; Iwaniec T; Alhenc-Gelas M; Musial J; Undas A
    Thromb Haemost; 2011 Aug; 106(2):379-81. PubMed ID: 21655678
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
    Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
    Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of patients with hereditary defects predisposing to thrombosis including pregnant women.
    Bauer KA
    Thromb Haemost; 1995 Jul; 74(1):94-100. PubMed ID: 8578533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic management of pregnancy complicated by congenital antithrombin III deficiency associated with pregnancy nephropathy].
    Massignon D; Pegaz-Fiornet M; Coeur P
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(3):299-304. PubMed ID: 3734344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Congenital antithrombin III deficiency. Use of concentrates in the prevention of thromboembolic episodes].
    Velasco F; Andrés P; Torres A
    Med Clin (Barc); 1985 Oct; 85(10):429. PubMed ID: 4079498
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxymetholone therapy in patients with familial antithrombin III deficiency.
    Shibuya A; Ninomiya H; Nakazawa M; Nagasawa T; Yoda Y; Abe T
    Thromb Haemost; 1988 Dec; 60(3):495-7. PubMed ID: 3238652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.